CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Cullinan Therapeutics, Inc. (CGEM) on Tuesday reported a loss of $49.4 million in its third quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 74 cents.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 79 cents per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGEM at https://www.zacks.com/ap/CGEM